What Causes Elevated C-Reactive Protein Levels?

Decode elevated C-Reactive Protein levels. Explore the difference between acute inflammatory spikes and persistent low-grade inflammation signals.

C-reactive protein (CRP) rises whenever the body mounts an inflammatory response, and the list of triggers is long: infections, excess body fat, poor sleep, autoimmune disease, surgery, certain medications, and even chronic psychological stress can all push levels up. CRP is made in the liver, driven mainly by a signaling molecule called interleukin-6, and it can surge from a baseline near zero to well over 100 mg/L within hours of a serious infection or injury. Understanding what drives those numbers up is useful because doctors increasingly use CRP not just to track acute illness but to gauge long-term cardiovascular and metabolic risk.

How the Liver Makes CRP

CRP is produced almost entirely by liver cells. The main trigger is interleukin-6 (IL-6), a signaling molecule released by immune cells and, as we’ll see, by fat tissue. When IL-6 reaches the liver, it activates a chain of molecular switches that turn on the CRP gene, and another signaling molecule, interleukin-1β, amplifies that signal further. CRP then floods into the bloodstream, where its concentration can rise a thousandfold in a day or two. The speed of that rise is part of what makes CRP clinically useful: it reflects what is happening in the body right now, not what happened weeks ago. Once the inflammatory stimulus resolves, CRP drops quickly, with a half-life of roughly 19 hours. That fast rise-and-fall pattern means a single CRP reading is a snapshot, and context matters enormously for interpreting it.

Infections Are the Most Dramatic Trigger

The steepest CRP spikes happen during bacterial infections. In children with bacterial pneumonia, average CRP levels reached about 133 mg/L, while those with viral pneumonia averaged around 41 mg/L. Sepsis, urinary tract infections, and other bacterial illnesses routinely push CRP above 40 mg/L, and values above 100 mg/L strongly suggest a bacterial cause. Viral infections can raise CRP too, but they tend to produce more modest elevations. One exception worth noting: adenovirus infections pushed CRP above 40 mg/L in about 38% of children studied, showing that not all viral infections keep CRP low.

Not just the peak level but the speed of the CRP rise helps distinguish bacterial from viral illness. One study found that bacterial patients had a CRP velocity roughly four times higher than viral patients. In the diagnostically tricky middle zone where CRP sits between 100 and 150 mg/L, a velocity above 4 mg/L per hour was seen only in bacterial cases. This is why doctors sometimes order serial CRP measurements rather than relying on a single draw.

Body Fat as a Chronic CRP Factory

If infections cause the sharpest CRP spikes, excess body fat is probably the most common cause of persistently elevated CRP in otherwise healthy people. Fat tissue, especially the visceral fat packed around your organs, actively produces IL-6, the same signaling molecule that tells the liver to make CRP. In people with vascular disease, visceral fat thickness was the single strongest contributor to circulating CRP levels. In obese individuals, CRP correlated with BMI and waist circumference, while IL-6 tracked more closely with visceral fat specifically.

The practical implication is that a moderately elevated CRP in someone who is overweight does not necessarily signal an acute problem. It often reflects the low-grade, ongoing inflammation that comes with carrying extra fat. Losing visceral fat tends to bring CRP down, though the relationship is complex and individual results vary.

Insulin Resistance and Metabolic Health

CRP and insulin resistance are intertwined in ways researchers are still working to untangle. In a large study of nondiabetic women, CRP was one of only two independent predictors of high fasting insulin (the other being BMI), even after accounting for other inflammatory markers. In both men and women, those with CRP in the highest third had roughly two to two-and-a-half times the odds of being insulin resistant compared with those in the lowest third. Elevated CRP levels have also been linked to an increased risk of eventually developing type 2 diabetes.

The question of which comes first, the inflammation or the metabolic dysfunction, remains open. Obesity drives both IL-6 production and insulin resistance, so CRP may partly be a bystander reflecting the same upstream problem. But the strength and independence of the CRP-insulin link suggest there may also be a feedback loop, where inflammation worsens metabolic control and poor metabolic control fuels more inflammation.

Cardiovascular Risk

Cardiologists have paid close attention to CRP for decades because it predicts heart attacks and strokes even in people whose cholesterol looks fine. A large study in the general population found that people with high-sensitivity CRP (hs-CRP) above 3 mg/L had a 34% higher risk of major cardiovascular events, a 61% higher risk of cardiovascular death, and a 54% higher risk of death from any cause, compared with those whose hs-CRP was below 1 mg/L. Even the more modest cutoff of 2 mg/L versus below 2 mg/L was associated with a 22% higher risk of major cardiac events.

These numbers don’t mean CRP itself is clogging your arteries. CRP is a marker of the inflammatory processes that contribute to plaque buildup and rupture. But because it’s cheap, widely available, and responds to interventions like exercise and weight loss, it has become a useful tool for gauging residual cardiovascular risk.

Autoimmune Disease

Autoimmune conditions raise CRP in uneven and sometimes counterintuitive ways. Rheumatoid arthritis (RA) typically drives CRP up substantially, and the CRP level tracks with how active the disease is. Lupus (SLE), on the other hand, is a striking exception: despite widespread inflammation and elevated IL-6, CRP levels in lupus patients tend to stay low or only slightly raised. The reasons for this lupus-CRP disconnect aren’t fully understood, but the clinical consequence is clear: a normal CRP in a lupus patient doesn’t mean the disease is quiet, and a sudden CRP spike in someone with lupus may point to a superimposed infection rather than a disease flare.

Other autoimmune conditions like inflammatory bowel disease, psoriatic arthritis, and vasculitis generally push CRP up in proportion to disease activity, making it a useful (if imperfect) monitoring tool alongside disease-specific markers.

Surgery and Physical Trauma

Any significant tissue injury triggers a CRP response, and surgery is the most predictable example. After major operations, CRP rises sharply from baseline, typically peaking on day two or three. In one study of major surgical patients who developed no infections, mean CRP rose by about 100 mg/L above baseline by day three and was still elevated at day seven, though it was declining by then. The same peak-at-two-to-three-days pattern held across different types of orthopedic and neurosurgical procedures.

Surgeons use this predictable trajectory to spot complications. If CRP fails to decline after day three, or if it starts rising again around day five, that secondary spike raises concern for a surgical-site infection. In one study of cranial surgery patients, a secondary CRP rise on day five had 90% specificity for identifying patients who would need readmission. For patients recovering from any surgery, a persistently high or rebounding CRP is something your surgical team will take seriously.

Sleep Deprivation and Sleep Apnea

Poor sleep reliably raises CRP, and it seems to do so through more than one pathway. In controlled experiments, both total sleep deprivation and partial sleep restriction increased CRP concentrations, while CRP stayed stable in control subjects who slept normally. In a population-based study, short sleep duration roughly doubled the odds of having an elevated hs-CRP.

Obstructive sleep apnea (OSA) is another potent driver. People with OSA had significantly higher CRP than controls, and the severity of apnea was proportional to CRP level even after adjusting for body weight and other factors. Since many people with OSA are also overweight, there’s a tangled web of overlapping causes here: the fat tissue, the disrupted sleep, and the intermittent drops in oxygen all feed into higher CRP. Treating OSA with continuous positive airway pressure tends to bring CRP down, though the data on that are mixed depending on how overweight the patient is.

Exercise and Its Two Faces

Exercise has a paradoxical relationship with CRP. A single bout of vigorous activity acutely raises CRP, but regular training over weeks and months lowers baseline levels. In patients with coronary artery disease, acute exercise caused a small but measurable CRP bump, yet after four months of training, the inflammatory response to the same exercise was blunted compared to a control group that didn’t exercise. Even in people with spinal cord injuries, those who were physically active had lower CRP than sedentary peers, and exercise interventions significantly reduced CRP.

If you’ve just had blood drawn for a CRP test and you did an intense workout the day before, mention that to your doctor. A mildly elevated reading in that context may reflect the acute exercise response rather than anything worrying.

Diet and Ultra-Processed Foods

What you eat affects CRP independently of how much you weigh. Diets heavy in ultra-processed foods are associated with higher inflammatory markers, while diets built around minimally processed whole foods are associated with lower inflammation. One recent study found that people getting 40–79% of their calories from ultra-processed foods had roughly 11–14% higher hs-CRP compared with those eating the least processed diets, after adjusting for potential confounders like BMI. The effect sizes are modest compared to, say, a bacterial infection, but they operate continuously over years and add to the cumulative inflammatory burden.

Depression and Psychological Distress

The link between CRP and depression is one of the more intriguing areas of research. In a study of more than 73,000 individuals, increasing CRP levels were associated with increasing odds of psychological distress, antidepressant use, and hospitalization for depression in a dose-response pattern. Those with CRP above 10 mg/L had nearly three times the odds of using antidepressants compared with those whose CRP was below 1 mg/L. In the UK Biobank, people with depression had higher CRP than controls (about 2.4 versus 2.1 mg/L), and the association held even after adjusting for health behaviors, BMI, and other factors.

About one-third of people with major depression show a clear low-grade inflammatory state, suggesting there may be a distinct subtype of depression with inflammatory roots. For these patients, CRP monitoring might eventually help guide treatment choices, potentially identifying people who could benefit from anti-inflammatory approaches alongside standard antidepressants. This is still an evolving field, but it underscores that CRP elevation isn’t purely a “physical” phenomenon.

Hormones and Medications

Certain medications and hormonal therapies directly affect CRP levels, sometimes in clinically important ways. The best-studied example is oral estrogen. In postmenopausal women, oral conjugated estrogens caused CRP to roughly double or even triple within weeks, while transdermal estradiol (delivered through a skin patch) had essentially no effect on CRP. A year-long trial confirmed this pattern: oral estrogen increased CRP by about 64% at twelve months, while transdermal estradiol showed only a 3% change that was not statistically meaningful. In one short-term comparison, oral estrogen drove a median CRP increase of 192%.

The mechanism is thought to involve the first-pass effect: oral estrogen goes directly to the liver via the digestive system, ramping up hepatic protein production including CRP. Transdermal estrogen bypasses the liver initially, entering the general circulation through the skin. If you’re on hormone therapy and your CRP comes back elevated, the delivery route of your estrogen may be a significant contributor worth discussing with your prescriber.

Statins, interestingly, work in the opposite direction. They reduce IL-6-driven CRP production in liver cells, which is part of why statins lower CRP independently of their cholesterol effects.

Cancer and Persistent Low-Grade Elevation

Growing tumors disrupt normal tissue and trigger a sustained inflammatory response that includes CRP elevation. The pentameric form of CRP that accumulates in blood during cancer tends to reflect an unresolved, simmering inflammation rather than the dramatic spike seen with infections. In patients already diagnosed with several types of solid cancers, elevated CRP is associated with a poorer prognosis. In apparently healthy people, mildly elevated CRP has been linked to a higher future risk of certain cancers, particularly lung and possibly colorectal cancer, though not breast or prostate cancer.

An important caveat: CRP is far too nonspecific to be useful as a cancer screening tool on its own. Dozens of common conditions elevate it. The cancer connection is more relevant when CRP is used alongside other markers to monitor treatment response or guide staging decisions in people who already have a diagnosis.

Your Genes Set the Baseline

Even when everything else is equal, some people run higher CRP than others because of genetic variation. Several common single-nucleotide differences in the CRP gene’s promoter region predictably influence how much CRP the liver makes at baseline. In one study, people carrying the highest-CRP-producing gene variant had average baseline CRP roughly twice that of people carrying the lowest-producing variant, and this difference persisted after accounting for age, sex, race, and smoking history. Other common gene variants in the CRP region have also shown strong associations with baseline CRP levels.

This genetic variability complicates interpretation. A CRP of 2.5 mg/L in someone who is genetically predisposed to higher production may mean something different from the same level in someone whose genes favor lower output. Most clinical guidelines don’t yet account for this, but it’s a reason why trends in your own CRP over time are often more informative than any single value.

Air Pollution and Environmental Exposures

Living in areas with higher levels of fine particulate matter (PM2.5) is associated with higher CRP, providing a biological link between air pollution and cardiovascular disease risk. One study found that a relatively modest difference in chronic PM2.5 exposure was associated with a roughly 24% increase in hs-CRP in men, though interestingly not in women in that particular cohort. People living in polluted urban areas, especially those who spend time outdoors during high-pollution days, may see their CRP drift upward for reasons that have nothing to do with their personal health behaviors.

Aging and the “Inflammaging” Phenomenon

CRP tends to creep up with age even in people who are otherwise healthy. This is part of a broader pattern sometimes called “inflammaging,” a chronic, low-grade inflammatory state that develops as the immune system ages. Contributing factors include accumulated cellular wear and tear, persistent viral infections (particularly cytomegalovirus, which most adults carry), changes in gut bacteria and intestinal permeability, and the gradual buildup of senescent cells that secrete inflammatory signals. This background inflammation likely explains why CRP-based cardiovascular risk cutoffs are less clean-cut in older adults, where a mildly elevated CRP is common and doesn’t always indicate a discrete treatable problem.

Gut Bacteria and Intestinal Permeability

An emerging line of research connects gut health to systemic CRP levels. When the balance of gut bacteria shifts toward more gram-negative species, these bacteria shed lipopolysaccharide (LPS), a component of their outer membrane that is a potent trigger of inflammation. In patients with type 2 diabetes and chronic kidney disease, elevated blood LPS was significantly correlated with higher levels of CRP and other inflammatory markers. The idea is that when the intestinal barrier becomes more permeable, bacterial products leak into the bloodstream and provoke a systemic inflammatory response that includes CRP elevation. This mechanism may contribute to the elevated CRP seen in metabolic syndrome and obesity, where gut barrier function is often compromised.

An Ancient Molecule

CRP is not a peculiarly human invention. It’s an evolutionarily conserved pattern-recognition molecule found in organisms from horseshoe crabs to fish to mammals. Wherever researchers have looked for CRP, from arthropods to primates, they’ve found it or a functional equivalent. Its core job across species is the same: recognizing certain molecules on the surfaces of damaged cells and pathogens, then flagging them for disposal by the immune system. The fact that this protein has been conserved for hundreds of millions of years of evolution speaks to how fundamental the inflammatory response it serves is to survival. It also means that much of the basic CRP research done in animal models translates reasonably well to humans, which has helped accelerate our understanding of what makes it rise and what that rise means for health.